Examining the role of emotion regulation, anger, and anxiety in misophonia: A network model
PLOS One · 2025
DOI: 10.1371/journal.pone.0329920 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Matthew R Hanna und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology & Neuroscience, Duke University, Durham, North Carolina, United States of America. Hauptthemen laut MEDLINE: Anger, Emotional Regulation, Anxiety. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: REAM Foundation.
Abstract (Originalsprache)
Background
Misophonia, characterized by intense negative reactions to specific sounds, is associated with significant emotional distress. The connections among misophonia severity and factors like emotion regulation, anxiety, and anger remain unclear. This study uses network analysis to clarify these relationships in adults with self-reported misophonia symptoms, identifying key intervention targets and processes driving symptom severity.
Methods
A community sample of adults with misophonia symptoms and impairment ( N = 205) completed psychometrically validated self-report measures, including the Duke Misophonia Questionnaire (DMQ), Misophonia Questionnaire (MQ), and assessments of emotion regulation, anxiety, and anger. Network analysis was conducted to identify associations among misophonia severity, anxiety, anger, and emotion regulation components. Centrality indices were used to evaluate the most influential factors in the network, and community detection was employed to explore underlying clusters.
Results
Misophonia severity was most strongly associated with emotional awareness, nonacceptance, anxiety, and anger. The network analysis revealed that nodes representing emotion regulation strategies, nonacceptance, and impulsivity had the highest centrality and expected influence values, indicating their significant role in the overall network. Community detection identified two distinct clusters: one reflecting emotion dysregulation and misophonia, and the other related to emotional clarity and awareness.
Conclusions
This study highlights the importance of nonacceptance, emotional awareness, anger, and anxiety in understanding misophonia severity. Interventions targeting anger, anxiety, and nonacceptance may be most effective in managing misophonia symptoms. Future research should explore these relationships longitudinally to better inform treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychology & Neuroscience, Duke University, Durham, North Carolina, United States of America.
- Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, United States of America.
- Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire, United States of America.
- Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America.
- Department of Psychiatry & Behavioral Sciences, Duke University School of Medicine, Durham, North Carolina United States of America.
ORCID-Profile: Matthew R Hanna, Amanda C Collins
Förderung
- REAM Foundation
Zitieren
APA
Hanna, M. R., Collins, A. C., Shan, Y., Chen, B., Wang, S., & Rosenthal, M. Z. (2025). Examining the role of emotion regulation, anger, and anxiety in misophonia: A network model. PLOS One. https://doi.org/10.1371/journal.pone.0329920
Vancouver
Hanna MR, Collins AC, Shan Y, Chen B, Wang S, Rosenthal MZ. Examining the role of emotion regulation, anger, and anxiety in misophonia: A network model. PLOS One. 2025. doi:10.1371/journal.pone.0329920
BibTeX
@article{Hanna2025,
author = {Hanna, Matthew R and Collins, Amanda C and Shan, Yanyan and Chen, Bill and Wang, Siyuan and Rosenthal, M Zachary},
title = {Examining the role of emotion regulation, anger, and anxiety in misophonia: A network model},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0329920}
}
EUVIMED